259 related articles for article (PubMed ID: 17203017)
21. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
Hjorth S; Auerbach SB
Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
Yamada J; Sugimoto Y
Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
[TBL] [Abstract][Full Text] [Related]
23. Serotonin 2C receptor antagonists induce fast-onset antidepressant effects.
Opal MD; Klenotich SC; Morais M; Bessa J; Winkle J; Doukas D; Kay LJ; Sousa N; Dulawa SM
Mol Psychiatry; 2014 Oct; 19(10):1106-14. PubMed ID: 24166413
[TBL] [Abstract][Full Text] [Related]
24. Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice.
de Groote L; Olivier B; Westenberg HG
Psychopharmacology (Berl); 2002 Aug; 162(4):419-24. PubMed ID: 12172696
[TBL] [Abstract][Full Text] [Related]
25. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
[TBL] [Abstract][Full Text] [Related]
26. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
27. Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.
Hjorth S; Bengtsson HJ; Milano S
Eur J Pharmacol; 1996 Nov; 316(1):43-7. PubMed ID: 8982649
[TBL] [Abstract][Full Text] [Related]
28. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?
Cremers TI; Wiersma LJ; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
Biol Psychiatry; 2001 Jul; 50(1):13-21. PubMed ID: 11457419
[TBL] [Abstract][Full Text] [Related]
29. Effects of 5-HT(6) receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat.
Dawson LA; Li P
J Neural Transm (Vienna); 2003 Jun; 110(6):577-90. PubMed ID: 12768354
[TBL] [Abstract][Full Text] [Related]
30. WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.
Hjorth S; Westlin D; Bengtsson HJ
Neuropharmacology; 1997; 36(4-5):461-5. PubMed ID: 9225270
[TBL] [Abstract][Full Text] [Related]
31. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram.
Cremers TI; de Boer P; Liao Y; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
Eur J Pharmacol; 2000 May; 397(1):63-74. PubMed ID: 10844100
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of 5-HT1B and 5-HT1D receptor antagonist effects on extracellular 5-HT levels in the guinea-pig brain following concurrent 5-HT1A or 5-HT re-uptake site blockade.
Roberts C; Boyd DF; Middlemiss DN; Routledge C
Neuropharmacology; 1999 Sep; 38(9):1409-19. PubMed ID: 10471095
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
van Amsterdam C; Seyfried CA
Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
[TBL] [Abstract][Full Text] [Related]
34. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
Hervás I; Artigas F
Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
[TBL] [Abstract][Full Text] [Related]
35. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine.
Hjorth S
Eur J Pharmacol; 1996 May; 303(3):183-6. PubMed ID: 8813565
[TBL] [Abstract][Full Text] [Related]
36. Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes.
Millan MJ; Veiga S; Girardon S; Brocco M
Psychopharmacology (Berl); 2003 Aug; 168(4):397-409. PubMed ID: 12721776
[TBL] [Abstract][Full Text] [Related]
37. Pharmacology of rapid-onset antidepressant treatment strategies.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice.
Calcagno E; Guzzetti S; Canetta A; Fracasso C; Caccia S; Cervo L; Invernizzi RW
Int J Neuropsychopharmacol; 2009 Jul; 12(6):793-803. PubMed ID: 19123962
[TBL] [Abstract][Full Text] [Related]
39. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.
Knobelman DA; Hen R; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805
[TBL] [Abstract][Full Text] [Related]
40. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality.
Pollier F; Sarre S; Aguerre S; Ebinger G; Mormède P; Michotte Y; Chaouloff F
Neuropsychopharmacology; 2000 Jan; 22(1):64-76. PubMed ID: 10633492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
